ACRVAcrivon Therapeutics Inc. Common Stock
2.210USD-7.53%Mkt Cap: 94.71M $P/E: —3d ago
Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generat…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap94.71M $
Enterprise Value6.43M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-77.91M $
Revenue/Share—
Last Price2.210 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees74
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.27
PEG—
EV/EBITDA-0.08
EV/Revenue—
P/S—
P/B1.09
EPS (TTM)-1.74
EPS (Forward)-1.73
52W Range
1.20043% of range3.560
52W High3.560 USD
52W Low1.200 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-69.24%
ROA-60.06%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-63.66M $
CapEx (TTM)1.67M $
FCF Margin—
FCF Yield-42.05%
Net Debt-87.84M $
Net Debt/EBITDA1.14
Balance Sheet
Debt/Equity0.02
Current Ratio7.99
Quick Ratio7.86
Book Value/Sh2.023 USD
Cash/Share2.099 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)11.50 USD
Upside (mean)+420.4%
Target Range7.000 USD – 19.00 USD
$7.000+420.4% to mean$19.00
# Analysts6
Ownership
Shares Out.42.85M
Float25.67M
Insiders15.41%
Institutions50.34%
Short Interest
Short Ratio3.0d
Short % Float4.73%
Short % Out.3.17%
Shares Short1.36M
Short (prev mo.)2.84M
Technical
SMA 501.731 (+27.6%)
SMA 2001.857 (+19.0%)
Beta1.86
S&P 52W Chg18.16%
Avg Vol (30d)429.55K
Avg Vol (10d)509.64K
Technical Indicators
RSI (14)66.9
MACD0.1173
MACD Signal0.0442
MACD Hist.+0.0731
BB Upper2.229 USD
BB Middle1.738 USD
BB Lower1.248 USD
BB Width56.45%
ATR (14)0.1384 USD
Vol Ratio (20d)0.90x